Three months treatment of active spondyloarthritis with imatinib mesylate: an open-label pilot study with six patients.

Added 5102 days ago (02.11.2006)
Authors: Eklund KK, Remitz A, Kautiainen H, Reitamo S, Leirisalo-Repo M
PubMed id: 17077157
Read article